Sign In
Buy FENC
$9.14
-0.84 (-8.42%)
At Close: Jun 03, 2026
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Fennec Pharmaceuticals Inc. (FENC) Investigation
04:45pm, Thursday, 13'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 13, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
10:00am, Wednesday, 12'th Aug 2020
RESEARCH TRIANGLE PARK, N.C., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that Rosty Raykov, Chief Executive Officer of Fennec wi
~ No Clinical Safety or Efficacy Issues Identified, and No Requirement for Further Clinical Data ~ ~ FDA Pre-Approval Inspection has Identified Deficiencies with the Facility of the Drug Product Manu
What Type Of Shareholders Own The Most Number of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Shares?
04:52pm, Friday, 07'th Aug 2020
If you want to know who really controls Fennec Pharmaceuticals Inc. (NASDAQ:FENC), then you'll have to look at the...
Fennec Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
10:00am, Wednesday, 05'th Aug 2020
~ FDA Set a PDUFA Target Action Date for PEDMARKTM of August 10, 2020 ~ ~ Strong Financial Position with $38.7 million in cash and no debt ~RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2020 (GLOBE NEWSWIRE
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
10:00am, Friday, 26'th Jun 2020
Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique formulation of sodium thiosulfate) for the prevention of pla
3 “Perfect 10” Stocks Under $10 With Big Upside Potential
02:50pm, Tuesday, 23'rd Jun 2020
Bull or bear market, no investment is a sure thing. Especially in the current financial environment, which remains riddled with uncertainty, finding compelling plays can be challenging for even the mo
Fennec Announces Results of Annual Meeting
10:04pm, Monday, 22'nd Jun 2020
RESEARCH TRIANGLE PARK, N.C., June 22, 2020 -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management.
Hedge Funds Souring On Fennec Pharmaceuticals Inc. (FENC)
01:50am, Monday, 15'th Jun 2020
In this article you are going to find out whether hedge funds think Fennec Pharmaceuticals Inc. (NASDAQ:FENC) is a good investment right now. We like to check what the smart money thinks first before
Fennec Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Business Update
10:00am, Thursday, 14'th May 2020
~ FDA Set a PDUFA Target Action Date for PEDMARKTM of August 10, 2020 ~~ Marketing Authorization Application (MAA) Validated by the EMA in February 2020 ~~ Strengthened its.
Fennec Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Business Update
10:00am, Thursday, 14'th May 2020
~ FDA Set a PDUFA Target Action Date for PEDMARKTM of August 10, 2020 ~ ~ Marketing Authorization Application (MAA) Validated by the EMA in February 2020 ~ ~ Strengthened its Financial Position Thro
Fennec Announces Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
10:00am, Friday, 08'th May 2020
Fennec Pharmaceuticals Inc. (FENC) (FRX.TO), a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate ) for the prevention of platinum-ind
Fennec Announces Closing of Public Offering
10:00am, Tuesday, 05'th May 2020
Fennec Pharmaceuticals Inc. (FENC) (FRX.TO), a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate ) for the prevention of platinum-ind
RDS.A, LYG among premarket losers
01:19pm, Thursday, 30'th Apr 2020
Chesapeake Energy (NYSE:CHK) -43% after preparing bankruptcy filing.On Deck Capital (NYSE:ONDK) -19% on Q1 earnings.Capricor Therapeutics (NASDAQ:CAPR) -16%.Capstead Mortgage (NYSE:CMO) -13% on
Fennec Announces Pricing of Public Offering
01:16pm, Thursday, 30'th Apr 2020
Fennec Pharmaceuticals Inc. (FENC) (FRX.TO), a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate) for the prevention of platinum-indu
